Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
09/07/26	€0.6600	+0.15%	16,092
08/07/26	€0.6590	-1.64%	41,279
07/07/26	€0.6700	-2.33%	66,216
06/07/26	€0.6860	+10.47%	132,195
03/07/26	€0.6210	-5.05%	65,368

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris Other stock markets 13:33:15 09/07/2026 BST			5-day change	1st Jan Change
0.6600 ^EUR	+0.15%		+0.92%	+9.63%

08:51am	Theraclion Announces Board Changes	CI
07:36am	Theraclion Appoints New Chairman	MT

Market Cap	48.18M 54.93M 44.48M 41.1M 77.91M 5.26B 79.47M 535M 208M 2.57B 206M 202M 8.93B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	56.03M 63.88M 51.73M 47.8M 90.6M 6.12B 92.42M 622M 242M 2.99B 240M 235M 10.39B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

08:51am	Theraclion Announces Board Changes	CI
07:36am	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
05-11	Theraclion raises nearly 6 million euros via units with warrants

07:00am	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
06-04	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
06-01	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU

Theraclion Share Price

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07:37am	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07:00am	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
06-19	Les puces américaines en weekend prolongé
06-19	Claude Lenoir nommé président par intérim de Theraclion

1 day	+0.15%
1 week	+0.92%
Current month	+5.10%
1 month	-9.59%
3 months	+39.53%
6 months	+8.20%
Current year	+9.63%

1 week	0.62	0.69
1 month	0.6	0.8
Current year	0.4	0.93
1 year	0.33	1.25
3 years	0.14	1.25
5 years	0.14	2.22
10 years	0.14	7.78

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	23/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	31/01/2018
Ari Kellen BRD	Director/Board Member	-	12/02/2019
Shawn Langer BRD	Director/Board Member	-	12/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+0.15%	+0.92%	+88.57%	+10.00%	54.93M
THERMO FISHER SCIENTIFIC, INC.	-1.26%	-0.62%	+19.70%	-0.70%	190B
INTUITIVE SURGICAL, INC.	-2.86%	+3.16%	-21.28%	+25.30%	147B
DANAHER CORPORATION	-1.76%	-1.52%	-4.94%	-18.15%	135B
BOSTON SCIENTIFIC CORPORATION	-1.08%	+4.06%	-56.24%	-14.30%	66.6B
EDWARDS LIFESCIENCES CORPORATION	-1.24%	+1.79%	+22.58%	+3.74%	53.92B
SIEMENS HEALTHINEERS AG	+0.18%	-2.00%	-27.72%	-31.08%	43.57B
AGILENT TECHNOLOGIES, INC.	-1.58%	-3.24%	+6.66%	+10.32%	36.45B
WATERS CORPORATION	-1.81%	-2.64%	+5.85%	+39.36%	36.15B
RESMED, INC.	-6.33%	+2.36%	-19.78%	-4.62%	29.69B
Average	-1.12%	+0.88%	+1.34%	+1.99%	73.8B
Weighted average by Cap.	-0.47%	+1.62%	-5.32%	+0.94%

	2024	2025
Net sales	830K 947K 766K 708K 1.34M 90.63M 1.37M 9.21M 3.58M 44.35M 3.55M 3.48M 154M	652K 743K 602K 556K 1.05M 71.18M 1.08M 7.24M 2.81M 34.83M 2.79M 2.73M 121M
Net income	-5.76M -6.56M -5.32M -4.91M -9.31M -628M -9.5M -63.9M -24.83M -308M -24.65M -24.11M -1.07B	-5.69M -6.49M -5.25M -4.85M -9.2M -621M -9.39M -63.15M -24.54M -304M -24.36M -23.83M -1.06B
Net Debt	3.41M 3.89M 3.15M 2.91M 5.52M 372M 5.63M 37.85M 14.71M 182M 14.6M 14.28M 633M	7.85M 8.95M 7.25M 6.7M 12.7M 857M 12.95M 87.15M 33.86M 419M 33.62M 32.88M 1.46B